ConsiGma®
Highly integrated solutions for continuous wet granulation, drying and tablet compression, the ConsiGma® GC lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled granulation and improved quality.
Available in 3 standard sizes, depending on the desired throughput (from 5 to 120 kg/h or 20,000 to 180,000 tablets/h to be verified by testing), the systems can be customized with a number of options to suit customer needs.
The Conductor 4.0 software ensures seamless control of the entire process and provides full reporting and track & trace.
Mainly targeted towards high value products (low dose API), orphan drugs and new chemical entities, the systems can be equipped with cleaning and containment features to handle highly potent formulations.
Read more about how GEA and its partners are implementing this technology to lead the way toward smaller, more flexible, continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing.
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
The ConsiGma® GD 25/80 offers standalone continuous twin-screw granulation and drying for small-scale R&D operations. It allows users to develop the process and achieve high granule quality on a compact unit.
The ConsiGma® TC modules are based on the GEA high-performance tablet coating technology that gently and accurately deposits controlled amounts of coating materials onto tablet cores — even if they are hygroscopic or friable.
All MODUL tablet presses are based on the Exchangeable Compression Module (ECM) concept. The ECM is completely isolated from the remainder of the machine, contains all product contact parts and can easily be removed from the press in a contained way. This means that the press itself remains powder-free and requires no cleaning.
Nur eine Zeiterscheinung oder die Zukunft? In jedem Fall wird die hundertprozentige Nachverfolgbarkeit von Vials für pharmazeutische Unternehmen, die Gefriertrocknung einsetzen, ein zunehmend wichtiges Thema. Wir bei GEA verfolgen diese Entwicklung aufmerksam und prüfen mögliche Lösungen. Vor allem aber verfügen wir über die Erfahrung, den Sachverstand und das Know-how, sie umzusetzen.
Es gab Zeiten, in denen die Worte „alkoholfreies Bier“ und „schmeckt gut“ kaum je im selben Atemzug genannt wurden – schon gar nicht von den Konsumenten. Doch alkoholarme und alkoholfreie Biere haben eine enorme Entwicklung hingelegt und sind heute vielfach als Erfrischungsgetränke etabliert. Nicht zuletzt dank der Technologie von GEA.
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.